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BUDDING SUPPORT: HOW PROFESSIONAL ATHLETES CAN
COMBAT OPIOID ABUSE BY ADVOCATING FOR THE FEDERAL
LEGALIZATION OF MARIJUANA

Jessica T. Osterlof*
I.

INTRODUCTION

The misuse of prescription opioids has been increasingly
recognized as one of the United States’ “most significant public
health problems.” 1 This is because opioid abuse can lead to
substance use disorders, physical impairment, mental impairment,
and even death. 2 Professional athletes in particular face the risk
of opioid misuse due to their constant injuries leading to chronic
pain. One proposed alternative to combat painkiller abuse is
medical marijuana.
Despite the growing acceptance of marijuana use for medical
purposes, it remains federally illegal. Professional athletes are
particularly affected by this prohibition, and many have expressed
their frustration with restrictions and their support for its
legalization. As more states legalize medical marijuana, a
patchwork of state laws has left groups, including professional
sports teams, with little guidance on how to regulate marijuana
within their drug policies. This Comment will explore the effects
of the Federal Controlled Substances Act (“CSA”) 3, evolving views
on marijuana as a medicine for chronic pain, how professional
athletes, in particular, are affected by the opioid epidemic, and
*J.D., 2022, Seton Hall University School of Law; B.A., summa cum laude, University
of Rhode Island, 2018. I would like to thank my adviser, Professor Jacob T. Elberg,
for his invaluable insight and guidance throughout the writing process, as well as the
Seton Hall Legislative Journal editors for their edits during the publication process.
1
Linda B. Cottler et al., Injury, Pain and Prescription Opioid Use Among
National Football League (NFL) Players, 116 DRUG & ALCOHOL DEPENDENCE 188,
188 (2011); see NAT’L INST. ON DRUG ABUSE, MISUSE OF PRESCRIPTION DRUGS RSCH.
REP. 3 (2020).
2 Cottler, supra note 1, at 188.
3 21 U.S.C. § 801 et seq.
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how these athletes can advocate for a federal solution in
rescheduling marijuana within the CSA.
Part II of this Comment provides an overview of current
federal and state marijuana regulations, evolving views on
marijuana as medicine, pain medication abuse in professional
athletes, and professional sports leagues’ current marijuana
policies. Part III analyzes current and expected barriers blocking
the federal legalization of marijuana. Lastly, Part IV poses
solutions for the advancement of medical marijuana use
legalization, particularly for professional athletes to treat injuries.
This Comment concludes that, while marijuana is increasingly
being recognized as a medicine and being legalized by the states,
marijuana remains federally illegal and professional athletes
provide a unique and public example of why a federal solution is
necessary.
In this Comment, I will argue that the unnervingly high rate
of painkiller abuse among current and retired professional
athletes provides a strong argument favoring the federal
legalization of medical marijuana. I will pose that these celebrity
athletes are in a unique position and, as a result, should advocate
for the legalization of medical marijuana while pushing for further
research, deliberation, and action by the federal government.
II. BACKGROUND
A. The Controlled Substances Act
The CSA was enacted in 1970 with the goal of classifying and
regulating various controlled substances in the United States. 4
Congress recognized that many controlled substances have
accepted medical purposes and are “necessary to maintain the
health and general welfare of the American people.” 5 Congress
sought to regulate the “illegal importation, manufacture,
distribution, and possession and improper use of controlled
substances,” because they have a “substantial and detrimental
effect on the health and general welfare of the American people.” 6
4
See Michael Gabay, The Federal Controlled Substances Act: Schedules and
Pharmacy Registration, 48 HOSP. PHARMACY 473, 473–74 (2013).
5
6

21 U.S.C. § 801(1).
21 U.S.C. § 801(2).
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The CSA was passed as part of a greater initiative during
President Richard Nixon’s term to strictly regulate the use,
distribution, and trade of controlled substances in the “War on
Drugs.” 7 Nixon infamously stated that drug abuse was “public
enemy number one” in the United States. 8 Although the goal of
the CSA was to regulate dangerous drugs, many question whether
there was an underlying political motive discriminating against
“hippies” and “blacks.” 9 Marijuana particularly comes under
scrutiny in debates over whether Congress had an ulterior motive
in passing the CSA.10 John Ehrlichman, Nixon’s domestic policy
adviser, in a 1994 interview expressed the motives of the Nixon
administration:
The Nixon campaign in 1968, and the Nixon White
House after that, had two enemies: the antiwar left
and black people. You understand what I’m saying?
We knew we couldn’t make it illegal to be either
against the war or black, but by getting the public to
associate the hippies with marijuana and blacks with
heroin, and then criminalizing both heavily, we
could disrupt those communities. We could arrest
their leaders, raid their homes, break up their
meetings, and vilify them night after night on the
evening news. Did we know we were lying about the
drugs? Of course we did. 11

7
War on Drugs, HISTORY.COM (Dec. 17, 2019), https://www.history.com/topics/
crime/the-war-on-drugs.

Id.
See DAN BAUM, LEGALIZE IT ALL: HOW TO WIN THE WAR ON DRUGS (2016); see
also Erik Sherman, Nixon's Drug War, An Excuse To Lock Up Blacks And Protesters,
Continues, FORBES (Mar. 23, 2016, 6:00 AM), https://www.forbes.com/sites/
8
9

eriksherman/2016/03/23/nixons-drug-war-an-excuse-to-lock-up-blacks-andprotesters-continues/?sh=5838a7c642c8; John Hudak, How Racism and Bias
WASH.
POST
(Apr.
28,
2016),
Criminalized
Marijuana,
https://www.washingtonpost.com/news/in-theory/wp/2016/04/28/how-racism-andbias-criminalized-marijuana/.
10
See Amy Nordrum, Why is Marijuana a Schedule I Drug?, INT’L BUS. TIMES
(Feb. 19, 2015, 1:33 PM), https://www.ibtimes.com/why-marijuana-schedule-i-drug1821426.
11 BAUM, supra note 9.
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Marijuana was “temporarily” placed on Schedule I when the CSA
was enacted, though remained subject to review. 12 “[T]he National
Commission on Marihuana and Drug Abuse issued a series of
reports” acknowledging that marijuana was not a serious threat to
the public health and recommending that federal law permit
possession of small amounts. 13 Despite the Commission’s advice,
many Americans and politicians were fearful of the drug’s negative
effect on society; ultimately, marijuana was kept on Schedule I. 14
“Under the CSA, substances are categorized into five
schedules” based on their medical “benefit and their potential to
result in abuse.” 15 The most restrictive is Schedule I. 16 Schedule I
substances have “no currently accepted medical use in treatment”
and pose a high potential for abuse. 17 “[H]eroin, lysergic acid
diethylamide (LSD), marijuana (cannabis), peyote, methaqualone,
and 3,4-methylenedioxymethamphetamine (‘Ecstasy’)” are all
listed as Schedule I substances. 18 Schedule II substances also pose
a high risk for abuse; however, Schedule II substances have “a
currently accepted medical use.” 19 A currently accepted medical
use is required for a drug to be placed on a schedule lower than
Schedule I. 20 The CSA does not define “medical use,” but the
“Drug Enforcement Administration [“DEA”] has developed
criteria that must be met to establish accepted medical use.” 21 The
following factors must be met: “the drug’s chemistry must be
known and reproducible, there must be adequate safety studies,
there must be adequate and well-controlled studies proving
efficacy, the drug must be accepted by qualified experts, and the

Nordrum, supra note 10.
Nordrum, supra note 10; see also U.S. NAT’L COMM’N ON MARIHUANA & DRUG
ABUSE, MARIHUANA: A SIGNAL OF MISUNDERSTANDING (1972).
14 Nordrum, supra note 10.
15 Alice Mead, Legal and Regulatory Issues Governing Cannabis and CannabisDerived Products in the United States, 10 FRONTIERS PLANT SCI. 1, 2 (2019).
12
13

16
17

Id.

21 U.S.C. § 812(b)(1).

Controlled Substance Schedules, U.S. DEP’T JUST. DRUG ENF’T ADMIN.
DIVERSON CONTROL DIV. [hereinafter DEA], https://www.deadiversion.usdoj.gov/
schedules/ (last visited July 6, 2022).
19 21 U.S.C. § 812(b)(2).
20 See 21 U.S.C. § 812(b)(2)–(5).
21 Mead, supra note 15, at 2–3.
18
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scientific evidence must be widely available.” 22 A substance may be
placed in Schedule II if it has a currently accepted medical use,
with severe restrictions.23 Schedule II substances include opioids
such as hydromorphone, methadone, meperidine, oxycodone,
fentanyl, morphine, opium, codeine, and hydrocodone. 24
Examples of Schedule II stimulants include amphetamine
(Adderall), methamphetamine, and methylphenidate (Ritalin). 25
Schedules III, IV, and V substances have a currently accepted
medical use and fewer abuse potential findings.26 Examples
include Xanax, Tylenol with codeine, and anabolic steroids such
as Depo-Testosterone.27
Reforming the CSA requires a rather comprehensive process.
To reduce restrictions on a controlled substance, an interested
person, the DEA, or the Department of Health and Human
Services (“HHS”)/Food and Drug Administration (“FDA”) may
initiate an action to reschedule a drug. 28 Rescheduling under
federal law is conducted through an administrative process where
the FDA conducts a full assessment of the substance’s abuse
potential, the DEA publishes a proposed rule in the Federal
Register, and the DEA responds to public comments or objections
before publishing a Final Rule rescheduling the substance. 29 The
Attorney General has delegated the responsibility to transfer a
substance between schedules to the Acting Administrator of the
DEA. 30 Congress may also schedule, reschedule, or deschedule a
substance by enacting a law. 31
Around the time that the National Commission on Marihuana
and Drug Abuse issued its report on marijuana guidance, an
organization known as the National Organization for the Reform
Mead, supra note 15, at 3.
21 U.S.C. § 812(b)(2).
24 DEA, supra note 18.
25 DEA, supra note 18.
26 21 U.S.C. § 812(b)(3)–(5).
27 DEA, supra note 18.
28 21 U.S.C. § 811(a); 21 C.F.R. § 1308.43(a).
29 Mead, supra note 15 at 3.
30
U.S. DEPT. OF JUST., DRUG ENF’T ADMIN., SCHEDULE OF CONTROLLED
SUBSTANCES: MAINTAINING MARIJUANA IN SCHEDULE I OF THE CONTROLLED
SUBSTANCES ACT (2016) [hereinafter DOJ].
31 Mead, supra note 15 at 3.
22
23
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of Marijuana Laws (“NORML”) filed the first petition asking the
DEA to reschedule marijuana to a lower tier. 32 The petition was
filed in 1972 and aimed to allow physicians to legally prescribe
marijuana. 33 DEA Administrative Law Judge, Francis L. Young,
heard the case and concluded that “[i]n strict medical terms,
marijuana is far safer than many foods we commonly consume . . .
[and] one of the safest therapeutically active substances.” 34 Young
concluded that “the provisions of the [CSA] permit and require the
transfer of marijuana from Schedule I to Schedule II,” and “[t]he
evidence in this record clearly shows that marijuana has been
accepted as capable of relieving the distress of great numbers of
very ill people.” 35 He also stated that it would be “unreasonable,
arbitrary and capricious for DEA to continue to stand between
those sufferers and the benefits of this substance in light of the
evidence in this record.” 36 Despite the court’s conclusion, the
petition was ultimately rejected in 1994 by the DEA in court after
a twenty-two-year battle. 37 The circuit court reasoned that “only
rigorous scientific proof” can satisfy the requirement of a substance
having “currently accepted medical use,” and that the finding on
marijuana did not meet this standard. 38
Subsequent petitions have been filed and declined by the
DEA. In 2011, the governors of Rhode Island and Washington
submitted a petition to the DEA to initiate proceedings requesting
that marijuana be rescheduled to Schedule II of the CSA.39 The
DEA accepted the petition and submitted the necessary data to
HHS requesting a scientific and medical evaluation and

32

Nordrum, supra note 10.

Removing Marijuana from the Schedule of Controlled Substances, DRUG
POL’Y ALL., (Jan. 10, 2019), https://drugpolicy.org/resource/removing-marijuanaschedule-controlled-substances.
34
Marijuana Rescheduling Petition, Opinion and Recommended Ruling,
Findings of Fact, Conclusions of Law and Decision of Admin. Law Judge, Docket
No. 86-22,
(Drug
Enf’t
Admin.
September 6,
1988)
at 58–59.
http://www.druglibrary.net/olsen/MEDICAL/YOUNG/ young.html.
35 Id. at 67–68.
36 Id. at 68.
37 Nordrum, supra note 10.
38 All. for Cannabis Therapeutics v. Drug Enf’t Admin., 15 F.3d 1131, 1137 (D.C.
Cir. 1994).
39 DOJ, supra note 30.
33
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scheduling recommendation for marijuana. 40
The HHS
recommended that Schedule I of the CSA should continue to
control marijuana, and the DEA is bound by the HHS’
recommendations as to scientific and medical matters. 41 The DEA
then set forth its findings in a published report in 2016 and
determined that marijuana still meets the criteria for placing a
substance in Schedule I of the CSA and therefore did not
reschedule the drug. 42
Ultimately, the DEA found there was not enough evidence to
show that marijuana has a currently accepted medical use, and
findings still showed that marijuana has a high potential for
abuse. 43 This rather recent determination by the DEA indicates
that rescheduling marijuana will prove no easy task for future
petitioners, as I will discuss below in the case of Washington v.
Barr. 44
B. State Marijuana Laws
The constitutional issue of state and federal law “butting
heads” is certainly relevant in the legalization of marijuana. The
CSA contains an anti-preemption clause, stating:
No provision of this title shall be construed as
indicating an intent on the part of the Congress to
occupy the field in which that provision operates,
including criminal penalties, to the exclusion of any
State law on the same subject matter which would
otherwise be within the authority of the State, unless
there is a positive conflict between that provision of
this title and that State law so that the two cannot
consistently stand together. 45
Courts have held that a state law is only preempted by the federal

40
41
42
43
44
45

DOJ, supra note 30.
DOJ, supra note 30.
DOJ, supra note 30.
DOJ, supra note 30.
925 F.3d 109 (2d Cir. 2019).
21 U.S.C. § 903.
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CSA if it is “physically impossible to comply with both state and
federal law” or if the state law “stands as an obstacle to the
implementation . . . of the full purposes” of the CSA.46 Marijuana’s
classification as a Schedule I substance under the CSA makes its
distribution a federal offense. 47 Despite this, many states have
taken the initiative to pass laws allowing regulated use. 48
In 1996, California became the first state to legalize medical
marijuana. 49 As of April 2022, thirty-seven states, the District of
Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands have
approved medical marijuana programs, and twenty are
comprehensive programs. 50 The National Conference of State
Legislatures (“NCSL”) determines that a program is
“comprehensive” if: (1) it provides “protection from criminal
penalties for using” marijuana for a medical purpose; (2) it
provides
access
to
marijuana
“through
home
cultivation, dispensaries or some other system that is likely to be
implemented”; (3) it “allows a variety of strains or products,
including those with more than ‘low THC’”; (4) it “allows either
smoking or vaporization of some kind of” marijuana
“products, plant material or extract”; and (5) it is not a limited trial
program.51 Typically, recreational marijuana contains higher
tetrahydrocannabinol (“THC”) levels than medical marijuana,
which is mostly cannabinoid (“CBD”). 52 THC is the main
psychoactive constituent of the cannabis plant, while CBD has
therapeutic effects which may alleviate symptoms. 53 States have
increasingly supported the legalization of marijuana, as evidenced
by the 2020 election, where five more states voted in favor of
46
Emerald Steel Fabricators, Inc. v. Bureau of Lab. and Indus., 230 P.3d 518,
528–29 (Or. 2010); see also Boultinghouse v. Hall, 583 F. Supp. 2d 1145, 1157 (C.D.
Cal. 2008); Ter Beek v. City of Wyoming, 823 N.W.2d 864, 871 (Mich. Ct. App. 2012).
47
State Medical Cannabis Laws, NAT’L CONF. STATE LEGS. (April 19, 2022),
https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx [hereinafter
NCSL].
48
49
50
51

Id.
Id.
Id.
Id.

Marc H., What’s the Difference Between Medical & Recreational Marijuana?,
CANNAMD (July 31, 2019), https://www.cannamd.com/whats-the-difference-betweenmedical-recreational-marijuana/.
52

53

Id.
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legalizing marijuana. 54 Some states, such as New York and Illinois,
have gone as far as approving regulations that allow doctors to
prescribe medical marijuana as a replacement for opioids in pain
treatment. 55
C. Evolving Views on Marijuana as Medical Treatment
While the federal government has not budged in rescheduling
marijuana, states increasingly have.56 A significant promoted use
is as a remedy for chronic pain. 57 The increasing legalization of
medical marijuana by the states indicates the evolving acceptance
of marijuana as a medicine; however, marijuana research results
have not proven strong enough to sway the federal government.
A 1999 study highlighted the potential medical use of
marijuana, finding: “[s]cientific data indicate the potential
therapeutic value of cannabinoid drugs, primarily THC, for pain
relief, control of nausea and vomiting, and appetite stimulation;
smoked marijuana, however, is a crude THC delivery system that
also delivers harmful substances.” 58 The study also recognized
psychological effects, finding: “[t]he psychological effects of
cannabinoids, such as anxiety reduction, sedation, and euphoria
can influence their potential therapeutic value.” 59 The study
concluded that “[t]hose effects are potentially undesirable in some
patients and situations and beneficial in others.” 60
54 Kelly Anne Smith, These States Passed Provisions to Legalize Marijuana in the
2020 Election, FORBES (Nov. 4, 2020), https://www.forbes.com/sites/advisor

/2020/11/04/these-states-passed-provisions-to-legalize-marijuana-in-the-2020election/?sh=6e29751d62e3.

New York State Department of Health Announces Opioid Replacement Now
a Qualifying Condition for Medical Marijuana, N.Y. STATE (July 12, 2018),
55

https://www.health.ny.gov/press/releases/2018/2018-07-12_opioid_replacement.htm;
Opioid Alternative Pilot Program, ILL. DEP’T OF PUB. HEALTH,
https://www.dph.illinois.gov/topics-services/prevention-wellness/medicalcannabis/opioid-alternative-pilot-program (last visited May 1, 2022).
56 See infra, Section II on State Marijuana Laws.
57
See Jayne Leonard, What are the Best Cannabis Strains for Chronic Pain?,
MEDICALNEWSTODAY, (Aug. 3, 2018), https://www.medicalnewstoday.com/articles
/322051.
58 JANET E. JOY, STANLEY J. WATSON, JR., & JOHN A. BENSON, JR., MARIJUANA AND
MEDICINE: ASSESSING THE SCIENCE BASE 4 (1999).
59 Id. at 108.
60

Id.

OSTERLOF (DO NOT DELETE)

786

9/5/2022 1:03 PM

SETON HALL LEGISLATIVE JOURNAL [Vol. 46:3

More recently, in 2017, the National Academies of Sciences,
Engineering, and Medicine released a report based on a
comprehensive review of 10,700 scientific abstracts from existing
research on marijuana health. 61 Conclusions from the report
suggest ways to improve marijuana research.62 One conclusion
reads: “There is conclusive or substantial evidence that cannabis
or cannabinoids are effective . . . [f]or the treatment of chronic
pain in adults . . . [a]s antiemetics in the treatment of
chemotherapy-induced nausea and vomiting . . . [and] [f]or
improving patient-reported multiple sclerosis spasticity
symptoms.” 63 Although the DEA concluded in 2016 that there was
not enough evidence to show that marijuana has a currently
accepted medical use, the 2017 report displays that there already
exists “conclusive” evidence to support effective medical treatment
through cannabis. 64 Additionally, the report indicates advanced
marijuana research is underway. 65 The initiatives taken by a
majority of the states to legalize medical marijuana also evidence
growing support for its benefits.
States are not the only advocates for medical marijuana and
its potential health benefits. Doctors and pharmacists have
provided support for the use of medical marijuana to reduce pain
and even to treat opioid addiction. 66 One organization, Doctors
for Cannabis Regulation (“DFCR”), advocates for the federal
legalization of marijuana in order to achieve “improved public
health, social justice, and consumer protections.” 67
DFCR
61
NAT’L ACADS. OF SCIS., ENG’G, AND MED., THE HEALTH EFFECTS OF CANNABIS
AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR
RESEARCH 31 (2017).
62
63
64
65

Id. at 9–12.
Id. at 13.
Id.
Id. at 9 (noting it is “a pivotal time in the world for cannabis policy and

research,” and recommending clinical trials of marijuana use for medical purposes
be conducted).
66 Charles John Gonzalez, Nicole Quackenbush, Sharon Stancliff, Cannabis as a
Substitute for Opioids , JAMA (July 16, 2019), https://jamanetwork.com/journals
/jama/fullarticle/2738280?resultClick=1; Franklin E. Caldera, Medical Cannibus as
an Alternative for Opioids for Chronic Pain: A Case Report , SAGE (Feb. 12, 2020),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016302/; DOCTORS FOR CANNABIS
REGUL., https://dfcr.org/ (last visited Mar. 20, 2022) [hereinafter DFCR].
67 DFCR Letter to the House in Strong Support of the MORE Act , DOCTORS FOR
CANNABIS REGUL.,
https://www.dfcr.org/post/dfcr-letter-to-the-house-in-strong-
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advocates for science-based regulation and the common good;
David L. Nathan, its founder and board president, stated, “[y]ou
don’t have to be pro-marijuana to oppose its prohibition.” 68 DFCR
promotes the creation of a legal and regulated system of marijuana
to combat the illicit drug trade and ensure public safety. 69 The
DFCR is just one group of doctors advocating for marijuana
legalization and it is becoming evident that its support is evolving.
The use of marijuana to treat chronic pain is a progressing
practice. In 2016, the Centers for Disease Control and Prevention
(“CDC”) reported that approximately 20.4 percent (50 million) of
U.S. adults suffered from chronic pain and eight percent suffered
from high-impact chronic pain. 70 The prevalence of chronic pain
has led doctors and patients to explore the use of marijuana as a
treatment. A 2015 article reviewing existing research on medical
marijuana as a treatment for chronic pain found that “several trials
had positive results, suggesting that marijuana or cannabinoids
may be efficacious” for treating some types of chronic pain
conditions.71 Dr. Kevin P. Hill concluded this article by noting that
medical marijuana and cannabinoids have “many potential
medical benefits,” but “physicians have a responsibility to provide
evidence-based guidance” when offering the use of medical
marijuana. 72

support-of-the-more-act (last visited Mar. 4, 2022).
68
Christopher Ingraham, More and More Doctors Want to Make Marijuana
Legal, WASH. POST (Apr. 15, 2016), https://www.washingtonpost.com/news/wonk
/wp/2016/04/15/more-and-more-doctors-want-to-make-marijuana-legal/.
69

Id.

James Dahlhamer et al., Prevalence of Chronic Pain and High-Impact Chronic
Pain Among Adults—United States, 2016, CDC MMWR 1001, 1003 (Sept. 14, 2018),
https://www.cdc.gov/mmwr/volumes/67/wr/mm6736a2.htm; Prevalence and Profile of
High Impact Chronic Pain, NIH, (Aug. 8, 2018), https://www.nccih.nih.gov
/research/research-results/prevalence-and-profile-of-high-impact-chronic-pain
(defining “High-impact chronic pain” as “pain that has lasted 3 months or longer
and is accompanied by at least one major activity restriction,” such as being unable
to attend school or work).
71
Kevin P. Hill, Medical Marijuana for Treatment of Chronic Pain and Other
Medical and Psychiatric Problems, JAMA 2474 (June 23/30, 2015),
https://jamanetwork.com/journals/jama/fullarticle/2338266?resultClick=1.
72 Id. at 2482.
70
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The outstanding issue noted by some doctors is the lack of
sufficient research.73 This is largely due to the federal restrictions
severely limiting clinical research on Schedule I controlled
substances.74 Doctors are placed with the burden of weighing the
risks and benefits of medical marijuana treatment for each
individual patient when deciding on the best course of treatment. 75
They must also keep up with ever-changing and conflicting state
and federal laws when recommending marijuana. 76 Until federal
restrictions are loosened, sufficient research to make uniform
methods of prescribing medical marijuana may not be attainable.
Doctors, however, are increasingly opting to prescribe medical
marijuana to treat patients where states have allowed it.
The current research on marijuana paints a preliminary path
to rescheduling cannabis. The CSA does not require that zero
detrimental effects exist for any drug for it to be on Schedule II,
III, IV, or V. 77 Many existing Schedule II substances have potential
for abuse and detrimental side effects.78 An argument that
marijuana has some detrimental effects should not prevent the
acknowledgment and recognition of its beneficial effects. That
said, further research is needed to solidify evidence of its benefits
that fit the DEA’s definition of “accepted medical use” for the CSA.
Also evolving is the accepted use of marijuana as a pain
remedy by the FDA itself. In determining whether marijuana has
accepted medical use, its potential medical benefits have been the
subject of much countervailing opinions and debate. Yet, cannabis
has proven medical benefits in particular formulations approved
by the FDA. 79 Two THC-based medications, prescribed in pill
form, have been approved for the treatment of nausea in cancer
patients undergoing chemotherapy and to “stimulate appetite in
patients with wasting syndrome due to AIDS.” 80 The FDA has also
Gonzalez, Quackenbush, & Stancliff, supra note 66.
Gonzalez, Quackenbush, & Stancliff, supra note 66.
75 Gonzalez, Quackenbush, & Stancliff, supra note 66.
76 Caldera, supra note 66 at 3.
77 See generally 21 U.S.C. § 812.
78 Methamphetamine, opioids, etc. all have potential for abuse that can lead to
addiction, physical and mental impairment, and death.
79
NATIONAL INSTITUTE ON DRUG ABUSE, MARIJUANA RESEARCH REPORT: IS
MARIJUANA SAFE AND EFFECTIVE AS MEDICINE? 1, 23 (2020).
73
74

80

Id.
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approved a CBD-based liquid medication, which is used for the
treatment of severe childhood epilepsy, Dravet syndrome, and
Lennox-Gastaut syndrome. 81 This federal approval by the FDA for
both CBD and THC-based drugs indicates accepted medical use.
This acceptance could prove beneficial in the path to federal
marijuana legalization to remedy chronic pain for professional
athletes.
D. Painkiller Abuse and Professional Athletes
As mentioned above, athletes are in a unique position
regarding the injuries they face and the need for a remedy to
perform and succeed in their careers.82 The use and abuse of
opioids is a serious issue afflicting the United States, and athletes
are one group who are heavily affected by this epidemic. 83
Professional athletes inevitably face the risk of physical injury with
each day of practice and performance. These constant injuries
have contributed to a dire need for pain medication and therapy
for many athletes. 84 While painkillers may seem to succeed in
numbing pain before or during a game, the everlasting effect of
addictive painkillers is often not adequately considered. Many
allegations have been made regarding the National Football
League’s (“NFL”) extensive reliance on painkillers to ensure the
players are able to participate in the game and thus increase league
and team revenues.85
In Dent v. NFL, 86 former NFL players brought suit in federal
court alleging, inter alia, that during their years playing in the
NFL, they received “copious amounts of opioids, non-steroidal
anti-inflammatory medications, and local anesthetics.” 87 The
plaintiffs claimed that the NFL encouraged them to take pain
81
82
83

Id. at 24.
See infra, Part II on evolving views of marijuana.
Clint Fletcher, Sports Injuries and Opioid Addiction: The Connection, BROAD

BREACH RECOVER CTR. (Nov. 13, 2019), https://meadowsmalibu.com/sports-injuriesand-opioid-addiction-the-connection/.
84

Id.

Michael B. Scallan, Painkillers for Profit Gains: How the Ninth Circuit’s
Revival of Dent v. NFL Could Hold the League Liable for Long-Term Injuries
Caused by its Administration of Painkillers, 46 S.U. L. REV. 325, 332 (2019).
85

86
87

Dent v. NFL, 902 F.3d 1109, 1115 (9th Cir. 2018).

Id.
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medications without prescriptions, that they were handed pills in
“small manila envelopes that often had no directions or labeling”
and were told to take whatever was in the envelopes.88 The players
further alleged that the NFL never warned them about “potential
side effects, long-term risks, interactions with other drugs, or the
likelihood of addiction,” constituting a lack of informed consent. 89
Lastly, the plaintiffs claimed that as a result of their use (which led
to overuse) of these pain medications, retired players suffer from
“permanent orthopedic injuries, drug addictions, heart problems,
nerve damage, and renal failure.” 90 The case has been to the Ninth
Circuit Court of Appeals twice, and in February 2021, the district
court denied the NFL’s motion to dismiss and recommended that
the case either proceed to trial or summary judgment, to avoid “a
third dismissal and overindulgence in judicial notice.” 91
Dent is just one of many cases where NFL players have alleged
misconduct by the NFL in providing painkillers without informing
the players of the serious side effects and future consequences. 92
Whether lawsuits are brought or not, current and former players
who speak out have made the outstanding issue of painkiller
addiction and abuse evident. A study conducted by researchers at
Washington University in St. Louis School of Medicine, which
surveyed 644 former NFL players, concluded that “retired NFL
players misuse opioid pain medications at a rate more than four

88
89
90

Id.
Id.
Id. The NFL argued in defense that the players’ claims were preempted by

§ 301 of the Labor-Management Relations Act. The Ninth Circuit Court of Appeals
held that the claims brought against the NFL by retired players neither arose from
collective bargaining agreements nor required their interpretation, and therefore,
“the players' claims regarding the league's alleged violation of federal and state laws
governing controlled substances were not preempted by § 301.” The Ninth Circuit
declined to inquire into the merits of the case and remanded to the district court.
91
Dent v. NFL, No. C 14-02324 WHA, 2021 U.S. Dist. LEXIS 31568, at *22
(N.D. Cal. Feb. 19, 2021).
92
See Ed Sherman, Mike Ditka, 1985 Bears Players Detail Team's Excessive
Painkiller Use, CHICAGO TRIBUNE (Jan. 17, 2015), https://www.chicagotribune.com/
sports/bears/chi-1985-bears-pain-killers-real-sports-20150117-story.html; see also
Andrew Withers, Painkillers, Concussions, Injuries, Oh My: NFL 'Player Safety', as
DETROIT
METRO
TIMES,
(July 7,
2016),
Explained
by
Megatron,
https://www.metrotimes.com/the-scene/archives/2016/07/07/painkillers-concussionsinjuries-oh-my-nfl-player-safety-as-explained-by-megatron.
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times that of the general population.” 93 The study stated that “new
evidence suggests that is occurring because players misused the
painkillers during their NFL careers.” 94 When the players were
asked about their prescription painkiller use while playing in the
NFL, forty-eight percent said they never used the drugs while
playing, while fifty-two percent of the retired players said they had
used prescription pain medication.95 Of the players who said they
used prescription painkillers while playing in the NFL, seventyone percent admitted to misusing the drugs—fifteen percent
admitted to misusing prescription pain medications within the
past thirty days of the survey.96 Notably, the study found that
“retired players who misused prescription painkillers while
playing in the NFL were three times more likely to misuse the
drugs today than those who used the pills only as prescribed while
playing.” 97 Furthermore, the “[p]revalence of current opioid use
was seven percent—three times the rate of the general
population.” 98
This study brought to light some concealed concerns within
the league. Dr. Eric Strain, Drug and Alcohol Dependence Editorin-Chief and Director of the Department of Psychiatry and
Behavioral Sciences at the Johns Hopkins Center for Substance
Abuse Treatment and Research, found the results “important” and
“valuable.” 99 He stressed his concern with athletes’ ease of access
to painkillers: “People will often continue to use drugs for reasons
that are different than the reasons that they started using them.” 100
Dr. Strain’s concern is that these athletes “start using these
93
John
Barr,
Painkiller
Misuse Numbs NFL Pain, ESPN
http://www.espn.com/espn/eticket/story?page=110128/PainkillersNews&redirected
=true (Last Visited Jul. 6, 2022). “Misuse” is defined as someone using more
painkillers than prescribed, using them without a prescription or obtaining
painkillers from a nonmedical source.
94 Id. The study is the first of painkiller use and misuse by former NFL players.
Directed by Linda Cottler, a professor of epidemiology in Washington University's
Department of Psychiatry, the study was commissioned by ESPN, with additional
funding provided by the National Institute on Drug Abuse, a division of the U.S.
Department of Health and Human Services.
95 Cottler, supra note 1.
96 Cottler, supra note 1, at 190–91.
97 Barr, supra note 93.
98 Cottler, supra note 1, at 188.
99 Barr, supra note 93.
100 Barr, supra note 93.
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[prescription] drugs for pain-relieving purposes but then . . . find
that [they are] unable to function without the use of these drugs.” 101
An example illustrating Dr. Strain’s concern is Dan Johnson,
a former NFL player who played tight end for the Miami Dolphins
in the mid-1980s. 102 Johnson “said he became addicted to
painkillers after two back surgeries that were necessary because of
injuries he suffered as an NFL player.” 103 Johnson reported that
he took nearly one thousand painkillers per month to overcome
the pain from injuries he sustained while playing in the NFL. 104 In
fact, Johnson broke so many bones during his time in the NFL that
his teammates referred to him as the “King of Pain.” 105 Most
concerning though is how Johnson acquired his painkillers—
through the internet, via overseas shipments, or through
acquaintances. 106 Johnson admits he was addicted to painkillers
and has also revealed that a few times his addiction led him to
contemplate suicide. 107 Fortunately, Johnson was able to end “his
addiction with the help of Suboxone, a narcotic used to treat
opioid dependence.” 108
Johnson’s method of medication acquisition is not unique
among NFL players. A Washington University study found that
sixty-three percent of the retired players using prescription pain
pills during their time in the NFL had obtained these medications
from a nonmedical source at least once. 109 In fact, many players
have admitted that “it was commonplace for the players to get
prescription painkillers from sources outside of NFL locker rooms,
either from unscrupulous doctors or drug dealers,” and one
former player stated these drugs were taken just before game
time. 110 The study showed that not only were former NFL players
experiencing moderate to severe pain daily, but these players were
Barr, supra note 93.
See generally Dan Johnsson, PRO FOOTBALL REFERENCE, https://www.profootball-reference.com/players/J/JohnDa02.htm (last visited Mar. 20, 2022).
103 Barr, supra note 93.
104 Barr, supra note 93.
105 Barr, supra note 93.
106 Barr, supra note 93.
107 Barr, supra note 93.
108 Barr, supra note 93.
109 Cottler, supra note 1, at 190–91.
110 Barr, supra note 93.
101
102
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also using and misusing painkillers given by their team doctors
without prescriptions when they complained of pain. 111
Misuse of pain medication does not end with the NFL.
Numerous National Hockey League (“NHL”) players have spoken
out about the lack of education given to professional athletes
regarding the risks of using pain medications to treat brutal
hockey injuries.112 Former NHL player Ryan Kesler spoke out
about pain medication abuse in the NHL, opening up about his
misuse of an anti-inflammatory drug, Toradol, for his chronic hip
pain. 113 Toradol is not approved for long-term use, 114 yet Kesler
revealed that he needed to take it in order to get through each
game. 115 Kesler has developed chronic inflammatory diseases
which his doctor says were likely triggered by his Toradol use. 116
Kesler said that he was unaware of any of the possible side effects
while taking the drug, exemplifying, as Rick Westhead of TSN
worries, that the NHL trainers and doctors have not focused
enough on educating the players on what medications they are
given. 117 NHL players are expected to be tough and push through
each game; as a result, many use pain medications before every
game in order to perform. 118
One distressing example of the NHL’s easy path to addiction
is the story of Derek Boogaard. Boogaard was a star enforcer in
the NHL, having played for the New York Rangers and Minnesota
Wild. 119 He “was widely regarded as the toughest man in the
Barr, supra note 93.
See generally Greg Wyshynski, Former Player Ryan Kesler Says There's Lack
of Education Across NHL in Risks of Pain Medications, ESPN (Sept. 26, 2020),
111
112

https://www.espn.com/nhl/story/_/id/29946533/former-player-ryan-kesler-says-therelack-education-nhl-risks-pain-medications.
113

Id.

Dave Stevenson, Former NHL Players Open Up About the Danger of Pain
Medications, FANSIDED (Oct. 23, 2020), https://puckprose.com/2020/09/23/former114

nhl-players-open-up-danger-pain-medications/. (Experts say the drug should not be
used for longer than five days.); See ROCHE LABRATORIES INC., TORADOL (KETOROLAC
TROMETHAMINE TABLETS) 1 (2013), https://www.accessdata.fda.gov/drugsatfdadocs
/label/2013/019645s019lbl.pdf.
115 Stevenson, supra note 114 (“‘I never wanted to hurt the team, so I knew I had
to play. To play, you have to take pain killers,’ Kesler said.”).
116 Wyshynski, supra note 112.
117 Wyshynski, supra note 112.
118 Wyshynski, supra note 112.
119
Stu Hackel, Derek Boogaard Alarming Example of NHL's Easy Path to
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NHL.” 120 Consequently, Boogaard suffered numerous injuries
requiring many surgeries resulting in terrible pain. 121 These
injuries, coupled with the pressing need to return to the ice and
keep fighting, led to a serious painkiller substance abuse disorder
and, eventually, his death by drug overdose.122 A jarring aspect of
Boogaard’s story is how easy it was for him to find pain
medications. He reportedly obtained pain medications including
hydrocodone and oxycodone from doctors for teams he did not
even play for.123 Boogaard’s story prompted many to question the
easy access to addictive drugs in the NHL, however, Kesler’s
statements reveal that the NHL seems to turn a blind eye to how
the players obtain drugs and get themselves back on the ice,
indicating their dire need for an alternative remedy.124
Unfortunately, these stories are not uncommon in
professional athletes. These athletes must show up and perform
to compete, but later could become addicted to the pain
medications that allowed them to do so. An important question
becomes when the players’ long-term health will become more
imperative than the guarantee that they play in every game. Does
marijuana present a better pain-relieving medicine to substitute
for these detrimental painkillers? If so, what will stand in the way
of reforming the professional leagues’ policies and federal law?

Addiction, SPORTS ILLUSTRATED (May 13, 2015), https://www.si.com/nhl/2015/05/
13/derek-boogaard-alarming-example-nhl-drug-addiction. "The role of enforcer[] in
the NHL is highly controversial. Although it is not an official position in hockey, it is
a well-known title for players whose jobs as fighters overshadow their play on the ice."
Anne Tjønndal, NHL Heavyweights: Narratives of Violence and Masculinity in Ice
Hockey, 70 PHYSICAL CULTURE & SPORT STUD. & RSCH. 55, 56 (2016) (citing Dennis
Coates et al., Does Violence in Professional Ice Hockey Pay? Cross Country Evidence
from Three Leagues in R. TODD JEWELL, VIOLENCE AND AGGRESSION IN SPORTING
CONTESTS 47 (2012)).
120 Anne Tjønndal, NHL Heavyweights: Narratives of Violence and Masculinity
in Ice Hockey, 70 PHYSICAL CULTURE & SPORT STUD. & RSCH. 55, 59–60 (2016).
121
Brett Popplewell, Fall of the Boogeyman, SPORTSNET (2011),
https://www.sportsnet.ca/hockey/nhl/fall-boogeyman-derek-boogaards-final-days/.
122
123
124

Id.

Hackel, supra note 119.
Wyshynski, supra note 112.
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E. Professional Sports Leagues’ Marijuana Policies
As more athletes become plagued by opioid addiction, players
have turned to other remedies for their pain. While concurrently
the public perception of medical marijuana evolves, 125 some
athletes are choosing the use of marijuana as a treatment for their
injuries.126 Athletes face a unique issue that increases their need
for marijuana law reform, namely that their job is to perform, and
they cannot perform if they are injured or in pain. Medical
marijuana could revitalize the way athletes manage their pain
before gameday. However, the current federal prohibition of
marijuana stands as a roadblock. It is a deterrent to professional
sports leagues contemplating permitting the use of marijuana.
This is evidenced by each league’s substance abuse policies,
discussed below.
The “Big Four” professional sports leagues in the United
States are the NFL, National Basketball Association (“NBA”),
NHL, and Major League Baseball (“MLB”). 127 The Big Four’s drug
policies do not vary substantially, except for their stances on
marijuana and punishments for noncompliance. 128 The NHL has
long been quite relaxed regarding restrictions and penalties for
marijuana use. The NFL and MLB’s policies have just recently
followed similar patterns in loosening formerly tight restrictions
on marijuana, as will be shown below.

125 Andrew Daniller, Two-thirds of Americans Support Marijuana Legalization,
PEWRESEARCH, (Nov. 14, 2019),
https://www.pewresearch.org/fact-tank/2019/11/14/americans-support-marijuanalegalization/ (stating that the share of U.S. adults who oppose legalization has fallen
from fifty-two percent in 2010 to thirty-two percent in 2019.).
126
Emily Kaplan, Is the NHL the Future of Marijuana in Pro Sports? Why it
Could Be, ESPN (Mar. 7, 2019), https://www.espn.com/nhl/story/_/id/26046596/isnhl-future-marijuana-pro-sports-why-be.
127
Christopher R. Deubert, I. Glenn Cohen, & Holly Fernandez Lynch,

Comparing Health-Related Policies and Practices in Sports: The NFL and Other
Professional Leagues, 1 HARV. J. OF SPORTS & ENT. L. 1, 14 (2017).
128 Id. at 20.
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The NFL in 2020 amended its labor agreement to cease the
suspension of players who test positive for marijuana. 129 The new
policy reduced the time when players are subject to testing “from
four months to the two weeks at the start of training camp.” 130
Additionally, a new threshold for a positive test was put in place,
“raising the allowed amount of THC from 35 nanograms to
150.” 131 This indicates that the League tolerates more marijuana
found in a player’s system than before. The NFL also moved away
from a punishment approach and toward providing treatment for
those that need it, which is determined by a medical board if the
player tests positive during training camp. 132 The 2020 Collective
Bargaining Agreement (“CBA”) reflected an important shift from
punitive to rehabilitative treatment of marijuana use.
MLB formerly listed marijuana on its banned substances list,
but only tested players if there was a “reasonable cause” to do so. 133
The punishment for a positive marijuana test was referral to the
Treatment Board for an evaluation that could result in a treatment
program that may consist of counseling, in- or out-patient
treatment, and follow-up testing. 134 A player would be suspended
only if they “flagrantly disregard the rules,” or were believed to be
a “threat” to fellow players’ safety. 135 In 2020, MLB removed
marijuana from its banned substances list and will no longer
punish players for testing positive. 136 The League retains “the right
to punish players who break existing marijuana laws, such as
possession and distribution, as well as for driving under the

Bill-in-Bangkok, CBA Nuggets: Marijuana Use by NFL Players in 2020 and
SBNATION, (May 10, 2020), https://www.hogshaven.com/2020/5/10/
See
21253409/cba-nuggets-marijuana-use-by-nfl-players-in-2020-and-beyond;
NFLPA,
Collective
Bargaining
Agreement
(Mar.
5,
2020),
https://nflpaweb.blob.core.windows.net/media/Default/NFLPA/CBA2020/NFLNFLPA_CBA_March_5_2020.pdf.
130 Bill-in-Bangkok, supra note 129.
131 Bill-in-Bangkok, supra note 129.
132 Bill-in-Bangkok, supra note 129.
133
Kendall Baker, Where the Major Sports Leagues Stand on Weed, AXIOS,
(Mar. 8, 2019), https://www.axios.com/marijuana-policies-sports-leagues-nhl-nba-nflmlb-57d6cc62-2d8c-4215-9609-0b72c0c63785.html.
134 Deubert, Cohen, & Lynch, supra, note 127, at 136.
135 Kaplan, supra, note 126.
136
MLB Communications (@MLB_PR), TWITTER (Dec. 12, 2019, 11:07 AM),
https://twitter.com/MLB_PR/status/1205157274676682752.
129

Beyond,
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influence.” 137 This essentially means the players cannot show up to
their practices, games, workouts, or meetings high on marijuana. 138
Additionally, club medical personnel are “prohibited from
prescribing, dispensing or recommending the use of marijuana or
any other cannabinoid” to players or officials. 139 The changes to
MLB’s policy came after the death of a player who overdosed on
opioids, discussed in Section IV.
The NHL has long offered a less stringent marijuana policy. 140
The NHL’s “Substance Abuse Program does not subject the
players to random drug testing” for disciplinary purposes. 141 The
League does not punish players who test positive for marijuana. 142
Rather, if a player shows abnormally high THC levels, NHL
physicians will recommend treatment to those who they determine
at their discretion may need to use the drug less. 143
The NBA’s 2017 CBA dissimilarly requires random marijuana
testing during the regular season.144 The punishment for a player’s
first positive test is to enter a substance abuse program.145 The
second offense is a $25,000 fine.146 The third offense results in a
five-game suspension, with five games added to each subsequent
positive test. 147 This makes the NBA the lone league in the Big
Four that still punishes players with fines for testing positive for
marijuana.
While leagues are slightly relaxing their restrictions on
marijuana, players are also increasingly performing in states where
marijuana is legal. In 2019, eighty-two percent of the 123 teams
of the Big Four played their home games in locations where either
137 Jeff Passan, MLB: Players Still Subject to Penalty for Using Pot, ESPN, (Feb.
28,
2020),
https://www.espn.com/mlb/story/_/id/28804440/mlb-players-subjectpenalty-using-pot.
138
139

Id.
Id.

Baker, supra note 133.
Deubert, Cohen, & Lynch, supra note 127, at 152.
142 Baker, supra note 133.
143 Baker, supra note 133.
144 Baker, supra note 133.
145 NATIONAL BASKETBALL PLAYERS ASSOCIATION, Article XXXIII, Sec. 8(b)(c)(A),
(Jan. 19, 2017), https://cosmic-s3.imgix.net/3c7a0a50-8e11-11e9-875d-3d44e94ae
33f-2017-NBA-NBPA-Collective-Bargaining-Agreement.pdf.
146 Id. at Article XXXIII, Sec. 8(b)(c)(B).
147 Id. at Article XXXIII, Sec. 8(b)(c)(C),(D).
140
141
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medical or recreational marijuana is legal. 148 That number has
likely risen after additional states legalized medical and/or
recreational marijuana in 2020.149 Additionally, teams travel out
of state for away games where there are different marijuana laws,
making it more difficult for players to continue marijuana
treatment and more confusing to know whether they are
complying with the law. Take, for example, one NFL team: the
New York Giants. The Giants’ 2021 schedule consisted of
seventeen games, eight home and nine away. 150 The team traveled
to Missouri, California, Florida, Louisiana, Illinois, Maryland,
Texas, and Pennsylvania. 151 In two of those states, marijuana is
legal both recreationally and medically. 152 In five, marijuana is
only medically legal, and each state has different medical
marijuana programs and restrictions.153 In one state, marijuana is
illegal recreationally and medically. 154 This schedule is just one
that exemplifies that these professional teams are increasingly
playing home games and traveling to perform in states where
medical marijuana is legal. As views on marijuana as a medicine
evolve, so could the players’ ability to lawfully choose it as a
treatment for their chronic pain.
Despite the slight liberation in marijuana policies and the
increasing number of states legalizing marijuana, the use of
marijuana as a medicine is still restricted by federal law, the CSA.
Additionally, leagues do not permit the use of medical marijuana
for the treatment of injuries, 155 which is a crucial change needed to
mitigate painkiller abuse. The classification of cannabis as a
148
149
150

Kaplan, supra note 126.
See NCSL, supra note 47.
NY Giants Schedule, 2021, N.Y. GIANTS, https://www.giants.com/schedule/

(last visited Mar. 20, 2022).
151
152
153
154
155

Id.
See NCSL, supra note 47.
See NCSL, supra note 47.
See NCSL, supra note 47.
But see Dana Perkins, What You Need to Know About Sports and CBD, Part

1, SORSE TECH., (Apr. 30, 2020), https://sorsetech.com/what-you-need-to-know-

about-sports-and-cbd-part-1/ (explaining in Major League Soccer (“MLS”), if a
substance is banned by the U.S. Anti-Doping Agency or FIFA, it is banned by the
League. Following WADA guidelines, use of CBD is allowed in MLS, but THC is not.);
see also MAJOR LEAGUE SOCCER, https://judiciary.house.gov/sites/democrats.judiciary.
house.gov/files/mlsconstitution_0.pdf (last visited Mar. 20, 2022).
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Schedule I drug still poses a major barrier to the leagues, as
evidenced by the National Basketball Players Association
Executive Director Michele Roberts’s statement in 2018 when she
said the NBA was “‘exploring’ medical exemptions for NBA
players to use medical cannabis [but that] federal law [stood] in the
way.” 156 Even though a majority of the Big Four Leagues prohibit
the use of medical marijuana by their athletes, the leagues seem to
have a less stringent stance on painkiller abuse.
III.

BARRIERS TO LEGALIZATION

A. Lack of Research
As with most legislative reforms, barriers will stand in the path
to rescheduling marijuana on the CSA. Politicians, citizens,
medical professionals, and researchers have participated in a hot
debate on the benefits and concerns of rescheduling cannabis to a
lower tier. The main conclusion or recommendation in many
research reports on marijuana and its health benefits is two-fold:
(1) evidence points to both benefits and detriments of its use; and
(2) further research is needed to come to more concrete
conclusions regarding its accepted medical use. 157 A concern of the
federal government is that marijuana remains unproven in terms
of safety or efficacy. 158 One of the first studies to research cannabis
in-depth, a 1999 Institute of Medicine Report, Marijuana and
Medicine: Assessing the Science Base, explored the history of
marijuana use as a medicine, its effects, and its potential. 159 The
report described how cannabinoids have shown significant
promise in basic experiments on pain, yet the ethical and logistical
difficulties of conducting pain experiments on human volunteers
156 TG Branfalt, NBA Players Union Boss Says MMJ Access Being Explored for
Players, GANJAPRENEUR (Feb. 20, 2018), https://www.ganjapreneur.com/nba-players-

union-boss-says-mmj-access-being-explored-for-players/.
157 See Valeriy Zvonarev, Tolulope A. Fatuki, & Polina Tregubenko, The Public
Health Concerns of Marijuana Legalization: An Overview of Current Trends, CUREUS
(Sept 30, 2019), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837267/.
158
Peter A. Clark, Kevin Capuzzi, and Cameron Fick, Medical Marijuana:
Medical Necessity Versus Political Agenda, MED. SCI. MONIT 249, 250 (Dec. 1, 2011),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628147/pdf/medscimonit-17-12ra249.pdf.
159
See generally ALISON MACK & JANET JOY, MARIJUANA AS MEDICINE? THE
SCIENCE BEYOND THE CONTROVERSY (2000).
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have strained the ability to confirm conclusions on marijuana’s
clinical pain relief abilities. 160 The report recommended continued
research of marijuana as medicine to elaborate potential benefits
and thorough epidemiological studies to define suspected risks
such as lung cancer from smoking marijuana.” 161 Many researchers
believe that the debate on the safety of marijuana as a medicine is
miscast and that medical use of potent, controlled psychoactive
drugs has not led to their abuse. 162 These researchers believe the
medical marijuana debate should focus on the promise of future
drug development rather than drug control policies.163
Although further investigative trials may be necessary to
overcome the administrative process, research and data do exist,
and it is up to advocates to push for continued research,
acceptance, and change.
B. Risk to Public Health
The lack of sufficient research is not the only barrier deterring
the federal government from rescheduling cannabis in the CSA.
The DEA report from 2016 discussed above in Part II, concluding
that marijuana shall remain in Schedule I of the CSA, sheds light
on the barriers advocates for rescheduling will face. 164 One major
concern of the DEA and HHS, which politicians and citizens will
likely share, is the risk to the public health associated with
marijuana use. 165 The DEA report discusses findings of risks such
as the effect on physical and/or psychological functioning of an
individual user, driving impairments, car accidents, and impaired
neurological function including altered perception, paranoia,
delayed response time, and memory deficits. 166
The HHS reviewed clinical studies testing the hypothesis that
marijuana is a gateway drug. 167 Its findings were limited and
concluded that: “although many individuals with a drug abuse
160
161
162
163
164
165
166
167

Id. at 79.
Id. at xii.
Id.
Id.
See DOJ, supra note 30.
See DOJ, supra note 30, at 4.
See DOJ, supra note 30, at 43.
See DOJ, supra note 30, at 45.
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disorder may have used marijuana as one of their first illicit drugs,
this does not mean that individuals initiated with marijuana
inherently will go on to become regular users of other illicit
drugs.” 168 One report published in 2019 conducted a review of the
current benefits and adverse effects of marijuana legalization in
various states across the United States. 169 Some public health risks
studied were: increased use after legalization, use by youths,
violent crime rates, fatal car accidents, suicide rates, increased
rates of homelessness, and effects of marijuana revenues. 170
These risks are undoubtedly important; however, they may be
less imminent if only medical marijuana is legalized. The issue
remains that the CSA does not consider recreational and medical
marijuana separately, it just classifies cannabis as a Schedule I
drug. 171 Therefore, the DEA needs to reschedule cannabis itself,
and then the legislature can set forth regulations for the
recreational and medical use of marijuana.
C. Existing Cannabis Drugs
The FDA has approved both CBD and THC-based drugs for
certain illnesses,172 which could prove beneficial for rescheduling;
however, it also could pose as a barrier to rescheduling because
one may argue that cannabis-based drugs already exist, and the
CSA is not hindering patients from receiving treatment. The
counterargument would be that the federal prohibition is
hindering certain groups who do not currently qualify as patients
who may be prescribed cannabis for chronic pain, i.e., athletes. An
important innovation would be the creation of a CBD or THCbased drug to help with extensive pain post-injury for athletes.
Athletes have used marijuana to treat pain regardless of the
consequences of violating their organization’s drug abuse policy.
If medical marijuana were permitted to be prescribed to treat their
pain, the numerous suspensions of players and alternative drug
abuse would diminish, and their pain could be remedied. Until
the federal government opens its eyes to the increased acceptance
168
169
170
171
172

See DOJ, supra note 30, at 45.

Zvonarev, Fatuki, & Tregubenko, supra note 157.
Id.
See 21 U.S.C. § 812.
See infra, Part II regarding evolving views on marijuana.
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of marijuana’s benefits to those who experience chronic pain, such
as athletes, it will be difficult to permit medical marijuana usage in
these professional sports leagues.
D. Stigma
It has become evident that there is a stigma surrounding
marijuana legalization and its effects on individuals and society.
Some former athletes are advocating for marijuana bans to remain
in professional sports. 173 This is partly because the drug remains
banned by federal law, illegal in some states still, and also because
of the impact on the leagues’, individual players’, and the sports’
reputation as stars that children emulate. 174 These professional
leagues are in a tough situation because there is a patchwork of
laws, which they will need to keep up with if they remove marijuana
bans. Between the federal prohibition and state’s nuanced stances
on marijuana, the leagues face a messy situation. Additionally, the
stigma on marijuana will make leagues reluctant to allow the use
of marijuana, especially while it is still federally illegal.
While these arguments for marijuana bans are valid, there are
options for these leagues. They could specify that they would allow
medical marijuana to treat injuries and would not permit
recreational use. The benefits of medical marijuana are arguably
better than the addiction issues from constant reliance on opioids.
Many celebrities and former athletes have expressed their support
for medical marijuana for athletes and the elimination of
marijuana bans in professional sports. 175 Some believe banning
marijuana in professional sports does not serve a logical purpose
and argue that it is only tested for political reasons. 176 Another
argument is that marijuana is not a performance-enhancing drug
and leagues should not penalize its use as harshly. 177 Many athletes
173
Joseph M Hanna, It’s Time to Get Real about Marijuana and Professional
Sports: Part 1, AMERICAN BAR ASS’N (Feb. 25, 2019), https://www.americanbar.org/

groups/litigation/committees/jiop/articles/2019/marijuana-professional-sports/.
174
Id.; see also Peter A. Clark, Kevin Capuzzi, and Cameron Fick, Medical
Marijuana: Medical Necessity Versus Political Agenda, MED. SCI. MONIT, (Dec. 1,
2011),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628147/pdf/medscimonit17-12-ra249.pdf.
175 Hanna, supra note 173.
176 Hanna, supra note 173.
177 Hanna, supra note 173.
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have retired early after multiple suspensions due to marijuana
usage. 178 Further, if marijuana was not a banned substance then
athletes could treat their pain and continue to progress in their
professional careers. Athletes are a prime example that federal
legalization is necessary to get rid of the patchwork of state laws
that have emerged. There are already evolving views regarding
the stigma surrounding marijuana, 179 and it is up to advocates like
the leagues and players to push lawmakers to revise restrictions.
IV.

SOLUTIONS

A. Players Advocating for Marijuana Rescheduling
Athletes are in a unique situation to make a change in society
and the law. This is due to the problems they face. For example,
athletes face imminent risk of injury and bigger problems, such as
inconsistent state laws on marijuana in the different states they
constantly travel to. Additionally, athletes are in the spotlight,
which creates an opportunity for very visible testing of differing
policies, and an opportunity for athletes to advocate for changes
in the law.
Many of the most basic individual constitutional rights were
debated and legalized after copious and persistent advocacy. 180
Advocates and scholars have offered marijuana as an alternative to
opioids in pain management for injuries suffered by athletes.181 In
2017, a retired NFL player, along with four other plaintiffs,
brought suit against the Attorney General and the DEA in the
Southern District of New York, seeking marijuana
decriminalization at the federal level. 182 In Washington v. Barr, the
district court dismissed the case for failure to exhaust
administrative remedies, since the plaintiffs did not first request

178
179
180

Hanna, supra note 173.
See supra, Part II on evolving views of marijuana.
History of Civil Rights Protests in Sports, Sports Mgmt. Degree Hub,

https://www.sportsmanagementdegreehub.com/history-civil-rights-protests-sports/
(last visited Mar. 20, 2022).
181
See generally Annie Bach Yen Nguyen, The Alternative to Opioids:

Marijuana's Ability to Manage Pain Caused by Injuries Sustained in the National
Football League, 19 TEX. REV. ENT. & SPORTS L. 63 (2019).
182

Washington v. Barr, 925 F.3d 109, 113 (2d Cir. 2019).
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rescheduling of the substance from the DEA. 183 The Second Circuit
Court of Appeals agreed that the plaintiffs must first exhaust
administrative remedies, however, the court noted that it was
“troubled by” the DEA’s history of dilatory proceedings. 184
Accordingly, the court concurred with the district court’s ruling,
but did not dismiss the case, and rather held it in abeyance and
retained jurisdiction to “take whatever action might become
appropriate if the DEA does not act with adequate dispatch.” 185
Assuming rejection was imminent, the plaintiffs decided not to
waste time attempting to petition the DEA and instead petitioned
directly to the United States Supreme Court. 186 On October 13,
2020, the Supreme Court denied the petition. 187 The Second
Circuit’s reference to the DEA’s troubled history of dilatory
proceedings could spark advocacy. If advocates were to build on
this, and encourage the DEA to listen, we could set a straighter
path to rescheduling marijuana. Some athletes have already
begun to advocate for change.
Although the Supreme Court will not hear the case, it
nonetheless serves as an important step in the right direction
toward athlete advocacy for change in the law. Numerous other
NFL players have advocated for the use of marijuana and
cannabinoids for pain treatment in athletes. One of the most
notable athlete advocates for marijuana legalization is former
Miami Dolphins running back, Ricky Williams. Williams was an
All-American, a Heisman trophy winner at the collegiate level, and
went on to have a highly successful NFL career. 188 Despite his clear
talent, Williams ultimately retired from the NFL after multiple
suspensions for violating the League’s substance abuse policy when
testing positive for marijuana. 189 Williams was using marijuana as
183
184
185

Id. at 114–15.
Id. at 113.
Id.

Sheilla Dingus, Ex-NFLer’s Cannabis Decriminalization Lawsuit May Be
Heading To The Supreme Court, ADVOC. FOR FAIRNESS IN SPORTS (Jan. 20, 2020),
186

https://advocacyforfairnessinsports.org/current-litigation/marvin-washington-vwilliam-barr/ex-nflers-cannabis-decriminalization-lawsuit-may-be-heading-to-thesupreme-court/.
187 Washington v. Barr, No. 20-148, 2020 U.S. LEXIS 4918, at 1 (Oct. 13, 2020).
188
Greg Bishop, Ricky Williams Takes the High Road, SPORTS ILLUSTRATED,
https://www.si.com/longform/2016/ricky-williams-weed/ (last visited Mar. 20, 2022).
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a pain-relief alternative that “worked for him in way painkillers did
not.” 190 Today, Williams owns a line of cannabis-based products
and advocates for the NFL to consider marijuana as a potential
pain relief alternative to opioids.191 Williams believes that the
stigma surrounding marijuana is a leading reason the NFL has not
made progressive changes to its drug policy. 192 Williams is in good
company as he is not the only professional athlete advocating for
lessened marijuana restrictions. Other major advocates for
marijuana use in professional sports include Rob Gronkowski, a
current NFL player campaigning for the use of CBD-based
products to treat injuries in the NFL, 193 and Al Harrington, a
former NBA player whose company markets and produces
cannabis products for medical and recreational use. 194 Both
Gronkowski and Harrington have found the use of CBD crucial to
their injury recoveries. 195
The road to rescheduling marijuana may not be so jagged if
more advocates follow in former NFL player Eugene Monroe’s
footsteps. Monroe is currently a lead advocate for medical
cannabis research and policy reform in the NFL. 196 As expressed
on his website, Monroe’s desire for marijuana reform stems from
the large volume of painkiller addictions among NFL athletes:
“I’m calling for the NFL to remove marijuana from the banned
substances list; fund medical marijuana research, especially as it
relates to CTE [chronic traumatic encephalopathy]; and stop
overprescribing addictive and harmful opioids.” 197 Monroe urges
the NFL to make these changes and persuades others to get
190

Id.

REAL WELLNESS HERBAL, Our Story: Transformation Rooted in Flexibility,
https://realwellnessherbal.com/our-story/ (last visited Mar. 6, 2021); Bishop, supra
note 188.
192 See generally Bishop, supra note 188.
193
Scott Jenkins, CBD Has Helped Rob Gronkowski Play Football Again,
SPORTSCASTING (May 21, 2020), https://www.sportscasting.com/cbd-has-helped-robgronkowski-play-football-again/.
194
Ben Pickman, Al Harrington and the Fight for Cannabis Use in the NBA,
SPORTS ILLUSTRATED (Mar. 11, 2020), https://www.si.com/nba/2020/03/11/alharrington-cannabis-viola-adam-silver-nba.
195 Jenkins, supra note 193; Pickman, supra note 194.
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involved and spur change by reaching out to key decisionmakers. 198
These players are not the first to argue for policy changes.
Professional athletes play a vital role in society and have made a
considerable impact on the law in areas such as racial and gender
inequality. 199 Athletes often find themselves in the spotlight, which
puts them in a unique position to spark reform in the law. If
medical marijuana were permitted as medicine for athletes’
injuries, the potential to decrease painkiller addiction and
overdose rates could be significant.
B. Big Four Policy Changes
The road to rescheduling marijuana is not quick, straight, or
easy; however, the issue of painkiller substance abuse disorders in
professional athletes is imminent and unnerving. A substantial
step toward the normalization of marijuana would be for
professional sports leagues to modify their drug policies to
endorse medical marijuana use for pain in states where medical
marijuana is legal. Such endorsements by the Big Four Leagues
for the use of medical marijuana to treat pain could potentially
decrease the widespread abuse of painkillers. A promising
development in this area is evidenced by some sports
professionals. The commissioner of the NBA has already stated
that he is open to reform and will “follow the science.” 200 The
commissioner of the NFL similarly stated he would “follow the
medicine” and the League would change its position if marijuana
can be proven to help. 201 MLB recently made a policy change,
which serves as an influential steppingstone to spark movement by
198
199

Id.
History of Civil Rights Protests in Sports, SPORTS MGMT. DEGREE HUB,

https://www.sportsmanagementdegreehub.com/history-civil-rights-protests-sports/
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SPORTS ILLUSTRATED, (June 22, 2007), https://www.si.com/more-sports/2007/06/22
/22-0the-most-influential-people-in-title-ix-history#gid=ci0255c9e5a00024a5&pid
=billie-jean-king.
200 Kaplan, supra note 126.
201 Mike Florio, Goodell Says League Would Consider Marijuana as a Concussion
Treatment,
NBC
SPORTS
(Jan.
23,
2014,
4:56
PM),
https://profootballtalk.nbcsports.com/2014/01/23/goodell-says-league-wouldconsider-marijuana-as-a-concussion-treatment/.
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other leagues. 202
Following the death of Los Angeles Angels Pitcher Tyler
Skaggs, 203 MLB changed its marijuana and opioid policies. 204 Tyler
Skaggs was a twenty-seven-year-old MLB player who died in his
hotel room during the 2019 MLB season. 205 Skaggs aspirated while
having “a mixture of fentanyl, oxycodone, and alcohol in his
system.” 206 The Angels’ director of communications had provided
Skaggs with illegally obtained oxycodone pills. 207 Effective in the
2020 season, MLB removed marijuana from its “drugs of abuse”
list and implemented mandatory tests for cocaine and opioids. 208
Players who test positive will be evaluated and prescribed a
treatment plan. 209 Those who fail to follow the treatment plan are
subject to punishment by the League. 210 Through this new policy,
both MLB and the Players Association aim “to protect athletes
from lethal and addictive substances.” 211 MLB’s Chief Legal
Officer, Dan Halem, noted: “[t]he opioid epidemic in our country
is an issue of significant concern to Major League Baseball. It is
our hope that this agreement—which is based on principles of
prevention, treatment, awareness and education—will help protect
the health and safety of our Players.” 212 MLB’s drug policy changes
202 Anthony Witrado, MLB’s New Marijuana Policy Could Spark Change In NFL
And NBA Policy, FORBES (Dec. 16, 2019, 11:27 AM), https://www.forbes.com

/sites/anthonywitrado/2019/12/16/mlbs-new-marijuana-policy-could-spark-changein-nfl-and-nba-policy/?sh=3dd997fb42a1.
203
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Reveals Opioids And Alcohol, NPR, (Aug. 30, 2019), https://www.npr.org/2019/
08/30/756044573/autopsy-of-los-angeles-angels-pitcher-tyler-skaggs-revealsopioids-and-alcohol.
204
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denote the grave concern caused by painkiller addictions, as well
as the shrinking concern for marijuana use.
The new MLB policy will also require all players and team
staff “to take classes on the ‘dangers of opioid pain medications
and practical approaches to marijuana’ during the next two
seasons.” 213 Under this policy, marijuana use will be treated
equivalent to alcohol use, meaning the “[p]layers caught using
cannabis will be referred to a treatment board,” but “cannot be
punished for failing to participate in a treatment program.” 214 The
White House Office of National Drug Control Policy applauded
the efforts of MLB and the Players Association by praising the
recent policy change which now prioritizes treatment over
punishment, even further stating its propensity to save lives. 215
Despite the liberating changes to MLB’s marijuana policy, the
League is not quite advocating for marijuana use as a pain
medication. If players can assist in adjusting the stigma and
advocating for a change in federal law, the leagues will have a more
open door to treat athletes with medical marijuana.
V.

CONCLUSION

The opioid epidemic remains an enormous public health
issue in the United States. The use of medical marijuana to treat
chronic pain is a proposed alternative to these dangerous,
addictive opioids. While marijuana legalization is a widely debated
topic and will require further research, professional athlete
advocacy and professional sports league policy modifications are
useful steps that can help educate the public and normalize the
acceptance of marijuana as a medicine. It is important to note that
athletes are just one of many groups in society that will be
benefited by rescheduling marijuana. Rescheduling marijuana
could benefit cancer patients, those who suffer from epilepsy, and
athletes who suffer painful injuries, but it also could detriment
those who misuse the drug. What is imperative to consider is that
each controlled substance carries both beneficial and detrimental
effects. But at what point is it more unjust and dangerous to
213
214
215
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deprive such a large portion of the population of a safer alternative
medicine? The road to reform is historically successful by
perseverance. Player advocacy coupled with policy changes is a
key step in the direction towards combating painkiller misuse by
professional athletes.

